sulfanilamide has been researched along with semaxinib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Duan, YT; Qin, YJ; Qiu, HY; Sang, YL; Wang, PF; Wang, YT; Wang, ZC; Wen, Q; Yang, YA; Zhang, X; Zhu, HL | 1 |
2 other study(ies) available for sulfanilamide and semaxinib
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis.
Topics: Antineoplastic Agents; Apoptosis; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; Chemistry Techniques, Synthetic; Coumarins; Drug Design; Humans; Isoenzymes; MCF-7 Cells; Melanoma, Experimental; Molecular Docking Simulation; Protein Conformation; Quantitative Structure-Activity Relationship; Substrate Specificity; Sulfonamides | 2013 |